|
|
||||||||
| 2.1 Diagnostics |
|
|
|---|
Fontes
Houston
Klion
Melrose
Noordin
Ottesen
Ramzy
Ravindran
Weil
Weerasooriya
Williams
| 2.2a Intervention Tools Chemotherapy |
|
|
|---|
Brandling-Bennett
Brown
Buettner
Coyne
Hoerauf
Kron
Lazdins-Helds
McCall
Prichard
Rajan
| 2.2b Clinical Drug Trials |
|
|
|---|
Basáñez
Bradley
Brown
Coyne
Kazura
Kron
Lazdins-Helds
Mand
McCall
Noordin
Ramzy
Saah
Stolk
Taylor
Weerasooriya
| 2.3 Clinical Management Trials |
|
|
|---|
Buettner
Noroes
Ryan
Seim
Shenoy
| 2.4 Program Implementation |
|
|
|---|
Balducci-Silano
Biswas
Dadzie
Ehrenberg
Kyelem
Lammie
Prichard
Richards
Streit
| 2.5 Monitoring and Evaluation |
|
|
|---|
Burkot
Das
El Setouhy
Fischer
Fontes
Habbema
Houston
Ichimori
Lam
Mathieu
Melrose
Ottesen
Sun
Weil
Williams
| 2.6 Epidemiology, Parasite Biology, Modeling |
|
|
|---|
Balducci-Silano
Biswas
Ehrenberg
El Setouhy
Gyapong
Habbema
Kyelem
Lam
Lustigman
Mathieu
Stolk
Sun
Twum-Danso
| 2.7 Vectors |
|
|
|---|
Das
Ichimori
Streit
2.8 Health Systems
|
|
|
|---|
| 3.1 Pathogenesis |
|
|
|---|
Addiss
Dreyer
Klei
Kumaraswami
Mackenzie
Malecela
Mand
Noroes
Nutman
Ryan
Seim
Shenoy
Steel
Taylor
| 3.2 Protective ImmunityVaccines |
|
|
|---|
King
Klei
Klion
Lustigman
Nutman
Rajan
Ravindran
3.3 Filarial Genomics
|
|
|
|---|
* Additional contributors were C. Curtis (London, United Kingdom); D. Durrheim (Townsville, Australia); E. Michael (London, United Kingdom); S. P. Pani (Pondicherry, India); A. Rocha (Recife, Brazil); P. Simonsen (Copenhagen, Denmark); S. Townson (London, United Kingdom). ![]()
Working Group Chairperson and/or Report Section Author. ![]()
Compiled by L. Barrett and D. McFarland based on a 1/2004 meeting in Crewe, United Kingdom (see attendees in Annex 3B). ![]()
| ||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |